Financial Management Professionals’s BioMarin Pharmaceuticals BMRN Stock Holding History

Financial Management Professionals’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2K	Hold	35	–	–	﹤0.01%	795
2026 Q1	$1.98K	Hold	35	–	–	﹤0.01%	733
2025 Q4	$2.08K	Hold	35	–	–	﹤0.01%	721
2025 Q3	$1.9K	Hold	35	–	–	﹤0.01%	719
2025 Q2	$1.92K	Sell	35 -6	-15%	-$353	﹤0.01%	756
2025 Q1	$2.9K	Buy	41 +6	+17%	+$404	﹤0.01%	699
2024 Q4	$2.3K	Hold	35	–	–	﹤0.01%	714
2024 Q3	$2K	Sell	35 -10	-22%	-$836	﹤0.01%	730
2024 Q2	$4K	Buy	45 +10	+29%	+$833	﹤0.01%	602
2024 Q1	$3K	Hold	35	–	–	﹤0.01%	689
2023 Q4	$3K	Hold	35	–	–	﹤0.01%	697
2023 Q3	$3K	Hold	35	–	–	﹤0.01%	651
2023 Q2	$3K	Hold	35	–	–	﹤0.01%	695
2023 Q1	$3K	Hold	35	–	–	﹤0.01%	744
2022 Q4	$4K	Hold	35	–	–	﹤0.01%	644
2022 Q3	$3K	Hold	35	–	–	﹤0.01%	662
2022 Q2	$3K	Hold	35	–	–	﹤0.01%	681
2022 Q1	$3K	Hold	35	–	–	﹤0.01%	698
2021 Q4	$3K	Hold	35	–	–	﹤0.01%	643
2021 Q3	$3K	Hold	35	–	–	﹤0.01%	642
2021 Q2	$3K	Buy	+35	New	+$2.77K	﹤0.01%	587
2019 Q2	–	Sell	-29	Closed	-$3K	–	317
2019 Q1	$3K	Hold	29	–	–	﹤0.01%	213
2018 Q4	$2K	Hold	29	–	–	﹤0.01%	224
2018 Q3	$3K	Buy	+29	New	+$2.9K	﹤0.01%	227

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Financial Management Professionals's BMRN Position: Q2 2026 in Review

Financial Management Professionals held its BioMarin Pharmaceuticals (BMRN) position steady in Q2 2026 at 35 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #795.

Financial Management Professionals first reported a position in BMRN in Q3 2018 and has held it in 24 quarters since. The position peaked at $4K in Q2 2024. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Financial Management Professionals held 35 shares of BioMarin Pharmaceuticals worth $2K as of Q2 2026.
Financial Management Professionals left its BioMarin Pharmaceuticals share count unchanged in Q2 2026.
BioMarin Pharmaceuticals made up ﹤0.01% of Financial Management Professionals's portfolio in Q2 2026, its #795 holding.
Financial Management Professionals first reported a position in BioMarin Pharmaceuticals in Q3 2018 and has held it in 24 quarters since.
Financial Management Professionals's BioMarin Pharmaceuticals position peaked at $4K in Q2 2024.
565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.